LET (Lidocaine 4%/Racepinephrine 0.225%/ Tetracaine 0.5%) Topical Solution

in Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients
DOI:
https://doi.org/10.37573/9781585285259.143
Restricted access